bisphosphocin nu-3
Nucleic acidexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2016 (NCT02737722)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bisphosphocin nu-3
- bisphosphocin nu-3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06020235 | Phase 2 | Nov 30, 2023 | Lakewood-Amedex Inc |
| NCT05276401 | Phase 2 | Mar 11, 2022 | Lakewood-Amedex Inc, PrimeVigilance LTD, Professional Education and Research Institute |
| NCT02737722 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2016 | Lakewood-Amedex Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lakewood-Amedex Inc | For profit | 3 | 3 | 1 | 2016 |
| PrimeVigilance LTD | For profit | 1 | 0 | 1 | 2022 |
| Professional Education and Research Institute | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1